Regulation

  • Read more: Stem cell patenting on the other side of the pond

    Stem cell patenting on the other side of the pond

    By Timo Minssen We are pleased to announce a new publication in the International Review of Intellectual Property and Competition Law (IIC). Our paper analyzes new case law in European stem cell patenting and compares these developments with the US situation and International treaties. Further information and an abstract is available below: Authors: Ana Nordberg & Timo Minssen, University of Copenhagen, Centre…

  • Read more: Peeling the Onion: How to Promote Pharmaceutical Innovation and Access to Medicine

    Peeling the Onion: How to Promote Pharmaceutical Innovation and Access to Medicine

    By Timo Minssen As mentioned in my earlier blog post, I decided to conclude this year by publishing a introductory speech that I gave on April 14th, 2015 at the 2015 Broad Institute Innovation & Intellectual Property Symposium. The speech was part of the session “Bringing Therapies to the Patients” and introduced a panel-discussion with Entrepreneur and Professors of…

  • Read more: Happy New Year: From “Weltschmerz” to Pharmaceutical Innovation

    Happy New Year: From “Weltschmerz” to Pharmaceutical Innovation

    By Timo Minssen Dear readers and colleagues, I would like to take this opportunity to wish you all a very happy, healthy and peaceful year 2016. Reaching the end of 2015, I cannot stop thinking about the year that has passed. Being a native German, living in Sweden and commuting every week over the bridge to Copenhagen in Denmark…

  • Read more: A Cost Conundrum for Treating Small Patient Populations

    A Cost Conundrum for Treating Small Patient Populations

    By Dalia Deak The issue of drug pricing has been thrust center stage (again) after Turing Pharmaceuticals raised the price of daraprim from $13.50 to $750 per dose. The public issued a loud outcry, the pharmaceutical industry condemned the move, and presidential candidates are now discussing drug prices (as discussed previously on this blog). The reactions…

  • Read more: The Impact of Broccoli II and Tomato II on European patents in conventional breeding, GMO’s and Synthetic Biology: A grand finale of a juicy patents tale?

    The Impact of Broccoli II and Tomato II on European patents in conventional breeding, GMO’s and Synthetic Biology: A grand finale of a juicy patents tale?

    By Timo Minssen I am pleased to announce our recent paper entitled “The Impact of Broccoli II & Tomato II on European patents in conventional breeding, GMO’s and Synthetic Biology: The grand finale of a juicy patents tale?”, which is available on SSRN, and forthcoming in Biotechnology Law Report, Vol. 34, Number 3 (June 2015), pp. 1-18….

  • Read more: Tomorrow (1/29): A “Natural” Experiment: Consumer Confusion and Food Claims, a lecture by Efthimios Parasidis

    Tomorrow (1/29): A “Natural” Experiment: Consumer Confusion and Food Claims, a lecture by Efthimios Parasidis

    A “Natural” Experiment: Consumer Confusion and Food Claims, a lecture by Efthimios Parasidis Thursday, January 29, 2015, 12: 00 PM Wasserstein Hall, Milstein West B                               Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] This event is free and open to the…

  • Read more: Upcoming Event (1/29): A “Natural” Experiment: Consumer Confusion and Food Claims, a lecture by Efthimios Parasidis

    Upcoming Event (1/29): A “Natural” Experiment: Consumer Confusion and Food Claims, a lecture by Efthimios Parasidis

    A “Natural” Experiment: Consumer Confusion and Food Claims, a lecture by Efthimios Parasidis Thursday, January 29, 2015, 12: 00 PM Wasserstein Hall, Milstein West B                               Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] This event is free and open to the…

  • Read more: Two new publications on “European patent strategies under the UPCA” and on “Synthetic Biology & Intellectual Property Rights”

    Two new publications on “European patent strategies under the UPCA” and on “Synthetic Biology & Intellectual Property Rights”

    By Timo Minssen I am pleased to announce two new publications on (1) “European patent strategies under the UPCA” and (2)  “Synthetic Biology & Intellectual Property Rights”: 1) Minssen, T & Lundqvist, B 2014, ‘The ”opt out” and “opt-in” provisions in the Unified Patent Court Agreement – Impact and strategies for European patent portfolios‘ ,…

  • Read more: A Physician Fights Surgery

    A Physician Fights Surgery

    By Lauren Taylor Physician and bioethicist Carla C. Keirns described the potentially dangerous impact of medicalization on her own childbirth in the Narrative Matters section of Health Affairs this month. A segment of that writing was reproduced in the Washington Post yesterday. In each piece, Keirns outlines the challenges she faced in vaginally delivering her…

  • Read more: Tomorrow: “Human Subjects Research Regulation” Book Launch

    Tomorrow: “Human Subjects Research Regulation” Book Launch

    Book Launch: “Human Subjects Research Regulation: Perspectives on the Future” Wednesday, October 22, 2014 12:00 PM – 1:00 PM Harvard Law School Library, Langdell Hall 4th Floor, Caspersen Room, 1557 Massachusetts Ave. This event is free and open to the public. Lunch will be served. For a list of our panelists, please visit our website. MIT Press recently…